                SEQUENCE LISTING

<110> CENTRO DE INVESTIGACIN PRNCIPE FELIPE 
      INSTITUTO DE SALUD CARLOS III
      UNIVERSIDAD CATLICA DE VALENCIA SAN VICENTE MRTIR
      UNIVERSITAT DE VALNCIA

<120> NEW BILATERALLY-SUBSTITUTED TRICYCLIC COMPOUNDS FOR THE TREATMENT
      OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1) INFECTION AND
      OTHER DISEASES

<130> VIH1

<160> 5

<170> BiSSAP 1.2

<210> 1
<211> 28
<212> RNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..28
<223> /organism="Artificial Sequence"
      /note="GCUGGGCGCACUUCGGUGACGGUACAGC"
      /mol_type="unassigned RNA"

<400> 1
gcugggcgca cuucggugac gguacagc                                       28


<210> 2
<211> 26
<212> RNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..26
<223> /organism="Artificial Sequence"
      /note="GCUGGGCGGACUUCGGUGCGCCCAGC"
      /mol_type="unassigned RNA"

<400> 2
gcugggcgga cuucggugcg cccagc                                         26


<210> 3
<211> 27
<212> RNA
<213> Artificial Sequence

<220> 
<221> source
<222> 1..27
<223> /organism="Artificial Sequence"
      /note="GCUGAUCUGACACUUCGGUGUCUCAGC"
      /mol_type="unassigned RNA"

<400> 3
gcugaucuga cacuucggug ucucagc                                        27


<210> 4
<211> 22
<212> PRT
<213> Artificial Sequence

<220> 
<223> TRQARRNRRRRWRERQRAAAAR

<400> 4
Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg Trp Arg Glu Arg Gln 
1               5                   10                  15      
Arg Ala Ala Ala Ala Arg 
            20          

<210> 5
<211> 27
<212> PRT
<213> Artificial Sequence

<220> 
<223> FITCGTRQARRNRRRRWRERQRAAAAR

<400> 5
Phe Ile Thr Cys Gly Thr Arg Gln Ala Arg Arg Asn Arg Arg Arg Arg 
1               5                   10                  15      
Trp Arg Glu Arg Gln Arg Ala Ala Ala Ala Arg 
            20                  25          

